Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fosaprepitant Combined With Tropisetron Plus Dexamethasone in Preventing Nausea and Emesis During Fractionated Radiotherapy With Weekly Cisplatin Chemotherapy in Cervical Cancer and Nasopharyngeal Cancer

NCT05564286 is registered in ClinicalTrials.gov with Shantou University Medical College as lead sponsor.

NCT NCT05564286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05564286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fosaprepitant Combined With Tropisetron Plus Dexamethasone in Preventing Nausea and Emesis During Fractionated Radiotherapy With Weekly Cisplatin Chemotherapy in Cervical Cancer and Nasopharyngeal Cancer
Lead sponsor
Shantou University Medical College
Phase
Phase 3
Overall status
Completed
Start date
July 1, 2021
Completion date
August 30, 2023
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiemetic, cervical cancer, chemotherapy-induced nausea and vomiting, nasopharyngeal cancer, radiation-induced nausea and vomiting